Pages that link to "Q34661023"

The following pages link to Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity (Q34661023):

Displaying 50 items.

• Targeting the gastrointestinal tract to treat type 2 diabetes (Q26738730) (← links)
• The Use of Rat and Mouse Models in Bariatric Surgery Experiments (Q26740015) (← links)
• How do patients' clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure? (Q26741527) (← links)
• The role of Gut Microbiota in the development of obesity and Diabetes (Q26744415) (← links)
• Recent advances in metabolic and bariatric surgery (Q26745203) (← links)
• Contribution of the distal small intestine to metabolic improvement after bariatric/metabolic surgery: Lessons from ileal transposition surgery (Q26749170) (← links)
• Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions (Q26751203) (← links)
• Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet (Q26752614) (← links)
• Fecal microbiota transplantation: in perspective (Q26765214) (← links)
• New mechanisms of metformin action: Focusing on mitochondria and the gut (Q26778766) (← links)
• Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review (Q26780440) (← links)
• Bariatric surgery and diabetes remission: Who would have thought it? (Q26783213) (← links)
• MANAGEMENT OF ENDOCRINE DISEASE: Metabolic effects of bariatric surgery (Q26784112) (← links)
• Intestinal Microbiota in Animal Models of Inflammatory Diseases (Q26795707) (← links)
• Assessing the human gut microbiota in metabolic diseases (Q26860785) (← links)
• The gut-adipose-liver axis in the metabolic syndrome (Q26995575) (← links)
• Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (Q26995945) (← links)
• Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms (Q27000617) (← links)
• Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? (Q27015789) (← links)
• Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation (Q27022777) (← links)
• Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome (Q28070321) (← links)
• Metabolic modeling with Big Data and the gut microbiome (Q28078364) (← links)
• A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery (Q28080484) (← links)
• The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes (Q28080912) (← links)
• Microbial endocrinology: the interplay between the microbiota and the endocrine system (Q28083570) (← links)
• Gut microbiota and non-alcoholic fatty liver disease (Q28085158) (← links)
• Peripheral signals mediate the beneficial effects of gastric surgery in obesity (Q28088425) (← links)
• FXR is a molecular target for the effects of vertical sleeve gastrectomy (Q28236848) (← links)
• Minireview: Gut microbiota: the neglected endocrine organ (Q28241240) (← links)
• Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism (Q28821039) (← links)
• Causality of small and large intestinal microbiota in weight regulation and insulin resistance (Q28828501) (← links)
• The Intestinal Microbiome in Bariatric Surgery Patients (Q28830297) (← links)
• The Gut Microbiota: The Gateway to Improved Metabolism. (Q30241392) (← links)
• The intestinal microbiome and surgical disease. (Q30248605) (← links)
• Obesity and overweight: Impact on maternal and milk microbiome and their role for infant health and nutrition (Q30250363) (← links)
• Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery (Q30277979) (← links)
• The gut microbiome in cardio-metabolic health. (Q30373247) (← links)
• The effect of PPI use on human gut microbiota and weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. (Q31161543) (← links)
• Understanding the Apothecaries Within: The Necessity of a Systematic Approach for Defining the Chemical Output of the Human Microbiome (Q33035147) (← links)
• Bariatric Surgery Prior to Index Screening Colonoscopy Is Associated With a Decreased Rate of Colorectal Adenomas in Obese Individuals (Q33551839) (← links)
• Postprandial Increase in Energy Expenditure Correlates with Body Weight Reduction in Patients with Type 2 Diabetes Receiving Diet Therapy (Q33567326) (← links)
• pH-Mediated Microbial and Metabolic Interactions in Fecal Enrichment Cultures. (Q33634286) (← links)
• The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery (Q33761529) (← links)
• Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease (Q33780172) (← links)
• Fecal microbiota transplantation in metabolic syndrome: History, present and future (Q33821397) (← links)
• Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients (Q33824299) (← links)
• Does gastric bypass surgery change body weight set point? (Q33838159) (← links)
• TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice (Q33907979) (← links)
• Metabolic tinkering by the gut microbiome: Implications for brain development and function (Q34129385) (← links)
• Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity (Q34146701) (← links)